235 related articles for article (PubMed ID: 10790830)
1. Supraphysiological thermal injury in Dunning AT-1 prostate tumor cells.
Bhowmick S; Swanlund DJ; Bischof JC
J Biomech Eng; 2000 Feb; 122(1):51-9. PubMed ID: 10790830
[TBL] [Abstract][Full Text] [Related]
2. In situ thermal denaturation of proteins in dunning AT-1 prostate cancer cells: implication for hyperthermic cell injury.
He X; Wolkers WF; Crowe JH; Swanlund DJ; Bischof JC
Ann Biomed Eng; 2004 Oct; 32(10):1384-98. PubMed ID: 15535056
[TBL] [Abstract][Full Text] [Related]
3. In vitro thermal therapy of AT-1 Dunning prostate tumours.
Bhowmick S; Coad JE; Swanlund DJ; Bischof JC
Int J Hyperthermia; 2004 Feb; 20(1):73-92. PubMed ID: 14612315
[TBL] [Abstract][Full Text] [Related]
4. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia.
Bhowmick P; Coad JE; Bhowmick S; Pryor JL; Larson T; De La Rosette J; Bischof JC
Int J Hyperthermia; 2004 Jun; 20(4):421-39. PubMed ID: 15204522
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thermal therapy in a prostate cancer model using a wet electrode radiofrequency probe.
Bhowmick S; Swanlund DJ; Coad JE; Lulloff L; Hoey MF; Bischof JC
J Endourol; 2001 Aug; 15(6):629-40. PubMed ID: 11552790
[TBL] [Abstract][Full Text] [Related]
6. Thermal therapy in urologic systems: a comparison of arrhenius and thermal isoeffective dose models in predicting hyperthermic injury.
He X; Bhowmick S; Bischof JC
J Biomech Eng; 2009 Jul; 131(7):074507. PubMed ID: 19640143
[TBL] [Abstract][Full Text] [Related]
7. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of the efficacy of thermal therapy in human renal cell carcinoma.
Walsh LP; Anderson JK; Baker MR; Han B; Hsieh JT; Lotan Y; Cadeddu JA
Urology; 2007 Aug; 70(2):380-4. PubMed ID: 17826524
[TBL] [Abstract][Full Text] [Related]
9. A parametric study of freezing injury in AT-1 rat prostate tumor cells.
Smith DJ; Fahssi WM; Swanlund DJ; Bischof JC
Cryobiology; 1999 Aug; 39(1):13-28. PubMed ID: 10458898
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of thermal dose during ablation therapy using quantum dot-mediated fluorescence thermometry.
Bensalah K; Tuncel A; Hanson W; Stern J; Han B; Cadeddu J
J Endourol; 2010 Dec; 24(12):1903-8. PubMed ID: 20858063
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells.
Roigas J; Wallen ES; Loening SA; Moseley PL
Prostate; 1998 Feb; 34(3):195-202. PubMed ID: 9492848
[TBL] [Abstract][Full Text] [Related]
12. A new model of thermal inactivation and its application to clonogenic survival data for WiDr human colonic adenocarcinoma cells.
Jordan A; Schmidt W; Scholz R
Radiat Res; 2000 Nov; 154(5):600-7. PubMed ID: 11025656
[TBL] [Abstract][Full Text] [Related]
13. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level.
Bischof JC; Smith D; Pazhayannur PV; Manivel C; Hulbert J; Roberts KP
Cryobiology; 1997 Feb; 34(1):42-69. PubMed ID: 9028916
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the thermal and tissue injury behaviour in microwave thermal therapy using a porcine kidney model.
He X; McGee S; Coad JE; Schmidlin F; Iaizzo PA; Swanlund DJ; Kluge S; Rudie E; Bischof JC
Int J Hyperthermia; 2004 Sep; 20(6):567-93. PubMed ID: 15370815
[TBL] [Abstract][Full Text] [Related]
15. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of hyperthermic toxicity by lonidamine in the Dunning R3327G rat prostatic adenocarcinoma.
Bloch WE; Lokeshwar BL; Ferrell SM; Block NL
Prostate; 1994; 24(3):131-8. PubMed ID: 8115278
[TBL] [Abstract][Full Text] [Related]
17. Towards patient specific thermal modelling of the prostate.
Van den Berg CA; Van de Kamer JB; De Leeuw AA; Jeukens CR; Raaymakers BW; van Vulpen M; Lagendijk JJ
Phys Med Biol; 2006 Feb; 51(4):809-25. PubMed ID: 16467580
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of mathematical models of cell death and thermal damage processes.
Pearce JA
Int J Hyperthermia; 2013 Jun; 29(4):262-80. PubMed ID: 23738695
[TBL] [Abstract][Full Text] [Related]
19. 'Relationship between thermal dose and cell death for "rapid" ablative and "slow" hyperthermic heating'.
Mouratidis PXE; Rivens I; Civale J; Symonds-Tayler R; Ter Haar G
Int J Hyperthermia; 2019; 36(1):229-243. PubMed ID: 30700171
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of cell membrane permeability changes at supraphysiological temperatures.
Bischof JC; Padanilam J; Holmes WH; Ezzell RM; Lee RC; Tompkins RG; Yarmush ML; Toner M
Biophys J; 1995 Jun; 68(6):2608-14. PubMed ID: 7647264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
